Friday, June 12, 2026

Patent directory Β· USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code β€” or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 1147 of 1,261
  1. US 6790939

    Anti-PSCA antibodies

    The Regents of the University of California Β· Granted Sep 14, 2004 Β· Expires Sep 9, 2024

    expired
  2. US 6790449

    Methods for producing self-replicating infectious RSV particles comprising recombinant RSV genomes or antigenomes and the N, P, L, and M2 proteins

    The United States of America, as represented by the Department of Health and Human Services Β· Granted Sep 14, 2004 Β· Expires Sep 9, 2024

    expired
  3. US 6790440

    Methods and compositions for promoting the maturation of monocytes

    Maxim Pharmaceuticals, Inc. Β· Granted Sep 14, 2004 Β· Expires Sep 9, 2024

    expired
  4. US 6790629

    Nucleic acid sequences encoding capsaicin receptor and capsaicin receptor-related polypeptides and uses thereof

    The Regents of the University of California Β· Granted Sep 14, 2004 Β· Expires Sep 9, 2024

    expired
  5. US 6790839

    Pharmaceutical administration of adenosine agonists

    CAN-FITE BIOPHARMA LTD. Β· Granted Sep 14, 2004 Β· Expires Sep 9, 2024

    expired
  6. US 6790615

    Methods and compositions for regulating cell cycle progression

    The Regents of the University of California Β· Granted Sep 14, 2004 Β· Expires Sep 9, 2024

    expired
  7. US 6790841

    2-hydroxymethylcyclopropylidenemethylpurines and -pyrimidines as antiviral agents

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN Β· Granted Sep 14, 2004 Β· Expires Sep 9, 2024

    expired
  8. US 6790936

    CAI resistance proteins and uses thereof

    The United States of America, as represented by the Department of Health and Human Services Β· Granted Sep 14, 2004 Β· Expires Sep 9, 2024

    expired
  9. US 6790953

    Ether compounds

    Esperion Therapeutics, Inc. Β· Granted Sep 14, 2004 Β· Expires Sep 9, 2024

    expired
  10. US 6790980

    Tannate compositions and methods of treatment

    First Horizon Pharmaceutical Corporation Β· Granted Sep 14, 2004 Β· Expires Sep 9, 2024

    expired
  11. US 6790877

    Bonding compositions for dental use

    KURARAY CO., LTD. Β· Granted Sep 14, 2004 Β· Expires Sep 9, 2024

    expired
  12. US 6787090

    Method of producing structures using centrifugal forces

    matRegen Corp. Β· Granted Sep 7, 2004 Β· Expires Sep 2, 2024

    expired
  13. US 6787650

    Urea compounds, process for producing the same and use thereof

    Takeda Chemical Industries Ltd. Β· Granted Sep 7, 2004 Β· Expires Sep 2, 2024

    expired
  14. US 6787352

    Polynucleotides encoding human ion-exchanger proteins

    Lexicon Genetics, Inc. Β· Granted Sep 7, 2004 Β· Expires Sep 2, 2024

    expired
  15. US 6787519

    Methods of treating disorders related to apoE

    The Regents of the University of California Β· Granted Sep 7, 2004 Β· Expires Sep 2, 2024

    expired
  16. US 6787145

    Recombinant proteins of a pakistani strain of hepatitis E and their use in diagnostic methods and vaccines

    The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Sep 7, 2004 Β· Expires Sep 2, 2024

    expired
  17. US 6787321

    Mammalian two-hybrid system for screening for modulators of the accumulation of metabolic products

    The Regents of the University of California Β· Granted Sep 7, 2004 Β· Expires Sep 2, 2024

    expired
  18. US 6787573

    Antiviral therapy

    Universitair Medisch Centrum Utrecht Β· Granted Sep 7, 2004 Β· Expires Sep 2, 2024

    expired
  19. US 6787333

    Retrovirus isolated from humans

    The United States of America, as represented by the Department of Health and Human Services Β· Granted Sep 7, 2004 Β· Expires Sep 2, 2024

    expired
  20. US 6787571

    Anti-inflammatory compounds derived from Pseudopterorgorgia elisabethae

    The Regents of the University of California Β· Granted Sep 7, 2004 Β· Expires Sep 2, 2024

    expired
  21. US 6787536

    Hydroxamic acid derivatives

    Darwin Discovery Limited Β· Granted Sep 7, 2004 Β· Expires Sep 2, 2024

    expired
  22. US 6787636

    Modified serum albumin with reduced affinity for nickel and copper

    New Century Pharmaceuticals, Inc. Β· Granted Sep 7, 2004 Β· Expires Sep 2, 2024

    expired
  23. US 6787365

    Inhibition of L-selectin and P-selectin mediated binding using heparin

    The Regents of the University of California Β· Granted Sep 7, 2004 Β· Expires Sep 2, 2024

    expired
  24. US 2004170566

    Dual functioning excipient for metal chelate contrast agents

    BRACCO INT BV [NL] Β· Granted Sep 2, 2004 Β· Expires Aug 28, 2024

    expired

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search β€” best for looking up a specific filing or applicant portfolio slice.